HylaPharm Media Coverage:

Kansas City Business Journal – “Entrepreneur: Out of the lab, and into the market” Requires subscription.
Science Coalition – “HylaPharm is selected to represent the University of Kansas at the Science Coalition’s Sparking Economic Growth conference in Washington D.C.”
Kansas City Business Journal – “3 corridor companies pitch at ‘Shark Tank’ for animal health” Requires subscription.
Kansas City Star – “KU cancer drug study finds success in dogs and could be promising for humans”
KSU – “Kansas State University veterinary researcher collaborates on aerosol-based treatment for lung cancer”
BND – “Her foster dog had cancer, but she never gave up hope. Now, the dog is healthy.”
Fox 4 News – “K.U. Medical Center drug shows promise in treating dogs with cancer”
KU Medical Center – “Successful targeted injectable chemotherapy treatment for dogs could lead to human trials”

Also published on Science Daily

Kansas City Business Journal – “Animal health: Human chemo treatment shows promise for pets” Requires subscription.
KU – “Baxendale Innovation Award honors KU researchers for cancer-fighting technology”
Animal Pharm – “HylaPharm aims to tackle canine cancer with first-of-its-kind chemotherapy”

KCTV5: Successful Cancer Treatment in Dogs Could Help Humans
KU – “KU startup earns $300K contract to develop cancer-fighting drug technology”
KU – “Startup company presenting at world’s largest angel investor event”
KU – “KU spinout HylaPharm begins producing cancer drug delivery technology”

Inside KU: Hylapharm – “Startup Firm Works to Improve Cancer Treatment”
KU – “Startup company presenting at world’s largest angel investor event”
LJWorld.com – “KU startup presents cancer-fighting technology to angel investors in Washington”
Kansas BioScience Authority
KC_Mag_small “Smart Drug Delivery: Modern Techniques Used to Develop Drugs”
KansasAngelsTaxCredit Kansas Angels Tax Credit
KansasAngelsTaxCredit Hylapharm Approved Company
vox_logo Vox Magazine – “MU Developing Drug to Treat Mouth Cancer in Dogs”